» Articles » PMID: 17095196

Neuronal Cell Cycle Re-entry Mediates Alzheimer Disease-type Changes

Overview
Specialties Biochemistry
Biophysics
Date 2006 Nov 11
PMID 17095196
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Evidence showing the ectopic re-expression of cell cycle-related proteins in specific vulnerable neuronal populations in Alzheimer disease led us to formulate the hypothesis that neurodegeneration, like cancer, is a disease of inappropriate cell cycle control. To test this notion, we used adenoviral-mediated expression of c-myc and ras oncogenes to drive postmitotic primary cortical neurons into the cell cycle. Cell cycle re-entry in neurons was associated with increased DNA content, as determined using BrdU and DAPI, and the re-expression of cyclin B1, a marker for the G2/M phase of the cell cycle. Importantly, we also found that cell cycle re-entry in primary neurons leads to tau phosphorylation and conformational changes similar to that seen in Alzheimer disease. This study establishes that the cell cycle can be instigated in normally quiescent neuronal cells and results in a phenotype that shares features of degenerative neurons in Alzheimer disease. As such, our neuronal cell model may be extremely valuable for the development of novel therapeutic strategies.

Citing Articles

From Fundamentals to Innovation in Alzheimer's Disease: Molecular Findings and Revolutionary Therapies.

Sighencea M, Popescu R, Trifu S Int J Mol Sci. 2024; 25(22).

PMID: 39596378 PMC: 11594972. DOI: 10.3390/ijms252212311.


An integrative systems-biology approach defines mechanisms of Alzheimer's disease neurodegeneration.

Leventhal M, Zanella C, Kang B, Peng J, Gritsch D, Liao Z bioRxiv. 2024; .

PMID: 38559190 PMC: 10980014. DOI: 10.1101/2024.03.17.585262.


Melatonin as a Harmonizing Factor of Circadian Rhythms, Neuronal Cell Cycle and Neurogenesis: Additional Arguments for Its Therapeutic Use in Alzheimer's Disease.

Shukla M, Vincent B Curr Neuropharmacol. 2023; 21(5):1273-1298.

PMID: 36918783 PMC: 10286584. DOI: 10.2174/1570159X21666230314142505.


Moesin is an effector of tau-induced actin overstabilization, cell cycle activation, and neurotoxicity in Alzheimer's disease.

Beckmann A, Ramirez P, Gamez M, Gonzalez E, De Mange J, Bieniek K iScience. 2023; 26(3):106152.

PMID: 36879821 PMC: 9984563. DOI: 10.1016/j.isci.2023.106152.


APC/C-Cdh1-targeted substrates as potential therapies for Alzheimer's disease.

Lapresa R, Agulla J, Bolanos J, Almeida A Front Pharmacol. 2023; 13:1086540.

PMID: 36588673 PMC: 9794583. DOI: 10.3389/fphar.2022.1086540.